Insurance status and head and neck radiotherapy interruption disparities in the Mid-Southern United States.

Head & Neck
Charles YarnDavid L Schwartz

Abstract

Relationships between health insurance coverage and radiotherapy (RT) interruption rates in patients with head and neck (H&N) cancer remain unclear. We performed a retrospective cohort study at our academic center. Days of RT interruption for individual patients were tabulated, analyzed for explanatory variables, and geographically mapped. 894 of 7526 (11.9%) scheduled treatment days were interrupted, impacting 149 of 216 (69%) patients. Medicaid/uninsured patients experienced a 7.3 day mean interruption (SD = 9.9) vs 3.4 days (SD = 5.2) for Medicare/private patients (P < .001). RT interruption was predicted by insurance status in multivariate analysis (P = .008). Higher RT interruption rates overlapped geospatially with low predicted median household income and racial minority neighborhoods. Unplanned treatment interruptions are a key source for H&N RT quality shortfalls in Medicaid/uninsured patients. This is the first geographic benchmarking of H&N RT delivery disparities across a complete metropolitan region, and will guide interventions studies to reduce interruption risk.

References

Mar 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M B BartonE Maki
Jul 1, 1991·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·R MickW R Panje
Jan 11, 1991·International Journal of Radiation Oncology, Biology, Physics·T F PajakL W Davis
May 1, 1991·Epidemiology·R S GreenbergD M Winn
Sep 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W Van den BogaertE van der Schueren
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Rafal TarnawskiAndrzej Wygoda
Dec 20, 2005·Nursing Outlook·Thomas C Ricketts, Laurie J Goldsmith
Jul 11, 2006·The Laryngoscope·Christine G Gourin, Robert H Podolsky
Aug 22, 2007·Archives of Otolaryngology--head & Neck Surgery·Amy Y ChenElizabeth M Ward
Nov 13, 2007·International Journal of Radiation Oncology, Biology, Physics·Ayşe Nur DemiralMünir Kinay
Jun 3, 2008·Seminars in Radiation Oncology·Michael L Steinberg
Sep 23, 2009·Archives of Otolaryngology--head & Neck Surgery·Megan Dann FesinmeyerScott D Ramsey
Feb 6, 2010·International Journal of Radiation Oncology, Biology, Physics·Megan Dann FesinmeyerScott D Ramsey
Mar 19, 2013·International Journal for Equity in Health·Jean-Frederic LevesqueGrant Russell
Oct 15, 2013·Cancer·Gene-Fu F LiuMichael T Spiotto
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 4, 2015·International Journal of Radiation Oncology, Biology, Physics·Nitin OhriMadhur Garg
Nov 22, 2016·International Journal of Radiation Oncology, Biology, Physics·Talha ShaikhThomas J Galloway
Feb 15, 2017·Journal of Oncology Practice·Jonas A de SouzaBonnie J Yap
Feb 16, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Shannon M ConroyScarlett Lin Gomez
Mar 8, 2017·Journal of Oncology Practice·Kimberly ThomasDavid L Schwartz
Mar 21, 2018·Advances in Radiation Oncology·Stanislav LazarevRichard L Bakst

❮ Previous
Next ❯

Citations

Jan 1, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Michael XiangBeth M Beadle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved